|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3 SEK | -0.33% |
|
-15.97% | -35.06% |
Klaria Pharma Holding AB (publ.) reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was SEK 5.87 million. Revenue was SEK 6.54 million compared to SEK 37.52 million a year ago.
Net loss was SEK 63.77 million compared to SEK 53.53 million a year ago. Basic loss per share from continuing operations was SEK 1.1 compared to SEK 1.03 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -35.06% | 2.94M | |
| +2.97% | 108B | |
| +10.21% | 104B | |
| +1.57% | 22.33B | |
| -12.77% | 22.19B | |
| -7.05% | 18.69B | |
| -37.64% | 17.74B | |
| -6.50% | 17.64B | |
| +6.00% | 14.05B | |
| +37.20% | 12.51B |
KLARIA PHARMA HOLDING AB 